Eléonore Weber-Delacroix

Eléonore Weber-Delacroix

Auto-generated profile, based on publicly available information

Eléonore Weber-Delacroix

Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025
Verified
Other
Open access
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
MPMarylou Panouillot
Marylou Panouillot
MLMarie Laviron
Marie Laviron
FLFrançois Lanthiez
François Lanthiez
TPTristan Philippe
Tristan Philippe
ABAlexandre Boissonnas
Alexandre Boissonnas
Gene lists of the DGE between treated and untreated subsets in human and mouse.

1 October 2025
Verified
Other
Open access
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
MPMarylou Panouillot
Marylou Panouillot
MLMarie Laviron
Marie Laviron
FLFrançois Lanthiez
François Lanthiez
TPTristan Philippe
Tristan Philippe
ABAlexandre Boissonnas
Alexandre Boissonnas
Tumor-associated macrophages (TAM) and regulatory T cells (Treg) are major immune components of the tumor microenvironment, promoting tumor growth and limiting the efficacy of chemotherapy in almost all cancer indications. Although Tregs are well known for their immunosuppressive activity toward the adaptive immune system, less is known about their regulatory activity toward the innate compartment. In this study, we have shown that in human and mouse lung cancer, chemotherapy transiently reduced Treg number and switched the mononuclear phagocyte (MP) landscape toward not only a proinflammatory signature but also an increased TGFβ-expressing TAM accumulation over time. Preventing Treg recovery further increased the recruitment of monocytes and limited TGFβ expression upon TAM differentiation, demonstrating that Tregs dampen the proinflammatory status of the MP compartment induced by chemotherapy and promote tumor relapse. Anti-TNFR2 antibody treatment during the Treg recovery phase affected the direct interaction between Tregs and MPs, increased the proinflammatory signature of the MPs, and improved survival in the mouse model. Targeting the cross-talk between tumor-associated Tregs and the MP compartment limits the reconstitution of an anti-inflammatory environment following chemotherapy and improves therapeutic outcome.

1 October 2025
Verified
Other
Open access
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
MPMarylou Panouillot
Marylou Panouillot
MLMarie Laviron
Marie Laviron
FLFrançois Lanthiez
François Lanthiez
TPTristan Philippe
Tristan Philippe
ABAlexandre Boissonnas
Alexandre Boissonnas
In vivo imaging of the lung shows Tregs (TdTomato+, red) crawling within the tumor nodules. Tumor vasculature (gray) was detected using Blue Evans.

1 October 2025
Verified
Other
Open access
PDF file
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
MPMarylou Panouillot
Marylou Panouillot
MLMarie Laviron
Marie Laviron
FLFrançois Lanthiez
François Lanthiez
TPTristan Philippe
Tristan Philippe
ABAlexandre Boissonnas
Alexandre Boissonnas
Myeloid landscape in human lung tumors

2 July 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
MPMarylou Panouillot
Marylou Panouillot
MLMarie Laviron
Marie Laviron
FLFrançois Lanthiez
François Lanthiez
TPTristan Philippe
Tristan Philippe
ABAlexandre Boissonnas
Alexandre Boissonnas
Tumor-associated macrophages (TAM) and regulatory T cells (Treg) are major immune components of the tumor microenvironment, promoting tumor growth and limiting the efficacy of chemotherapy in almost all cancer indications. Although Tregs are well known for their immunosuppressive activity toward the adaptive immune system, less is known about their regulatory activity toward the innate compartment. In this study, we have shown that in human and mouse lung cancer, chemotherapy transiently reduced Treg number and switched the mononuclear phagocyte (MP) landscape toward not only a proinflammatory signature but also an increased TGFβ-expressing TAM accumulation over time. Preventing Treg recovery further increased the recruitment of monocytes and limited TGFβ expression upon TAM differentiation, demonstrating that Tregs dampen the proinflammatory status of the MP compartment induced by chemotherapy and promote tumor relapse. Anti-TNFR2 antibody treatment during the Treg recovery phase affected the direct interaction between Tregs and MPs, increased the proinflammatory signature of the MPs, and improved survival in the mouse model. Targeting the cross-talk between tumor-associated Tregs and the MP compartment limits the reconstitution of an anti-inflammatory environment following chemotherapy and improves therapeutic outcome.

9 April 2026
Verified
Thesis
Closed access
EWEléonore Weber-Delacroix
Eléonore Weber-Delacroix
Les thérapies conventionnelles, telles que la chimiothérapie, demeurent la principale ligne d'intervention pour la majorité des cas de cancer, malgré des effets secondaires importants et un taux de récidive élevé. Les macrophages associés aux tumeurs (TAM) et les lymphocytes T régulateurs (Treg) sont en partie responsables de l'échec thérapeutique en raison de leur effet immunosuppresseur. Comprendre les processus de résistance aux thérapies liés à la reconstitution de l'axe anti-inflammatoire et immunosuppresseur porté par les TAM et les Treg est essentiel pour éviter ces rechutes. Mon projet de thèse vise à comprendre l'impact des thérapies anticancéreuses sur les macrophages associés aux tumeurs et s'articule autour de deux axes : la caractérisation des macrophages dans les organes en condition d'homéostasie, ainsi que l'impact de la chimiothérapie sur les macrophages associés aux tumeurs et le rôle de leurs interactions avec les Treg dans la récupération de l'immunosuppression. Dans le cadre du premier projet, nous montrons que l'hétérogénéité des macrophages résidant dans les tissus à l'homéostasie est dictée par la composition du tissu au niveau sous-anatomique et que chaque sous-ensemble est régulé par une combinaison distincte de facteurs moléculaires. Dans le cadre du second projet, nous montrons que la chimiothérapie induit des modifications importantes dans le compartiment des macrophages associés aux tumeurs, tant dans les cancers du poumon non à petites cellules chez l'homme que dans un modèle murin. Nous mettons en évidence que les Treg régulent l'équilibre entre monocytes et TAM après la chimiothérapie, favorisant une polarisation anti-inflammatoire. De plus, une thérapie combinant chimiothérapie et anticorps anti-TNFR2 perturbe ces interactions, induisant une réponse pro-inflammatoire des TAM et augmentant la survie des souris dans les modèles tumoraux.